...
首页> 外文期刊>Journal of Antimicrobial Chemotherapy >Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype
【24h】

Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype

机译:达托霉素对金黄色葡萄球菌hemB突变体表现出小菌落变异表型的药效学

获取原文
获取原文并翻译 | 示例

摘要

Objectives Staphylococcus aureus small colony variants (SCVs) are slow-growing morphological variants associated with persistent infections. While vancomycin activity has been shown to be attenuated against SCVs of S. aureus, few data exist regarding daptomycin. The objective was to evaluate the pharmacodynamics of daptomycin against defined S. aureus mutants displaying the SCV phenotype.
机译:目的金黄色葡萄球菌小菌落变异体(SCV)是与持续感染相关的生长缓慢的形态变异体。虽然万古霉素的活性已被证明对金黄色葡萄球菌的SCV减弱,但关于达托霉素的数据很少。目的是评估达托霉素对确定的表现出SCV表型的金黄色葡萄球菌突变体的药效学。

著录项

  • 来源
    《Journal of Antimicrobial Chemotherapy 》 |2009年第5期| p.977-981| 共5页
  • 作者单位

    1Laboratory for Antimicrobial Pharmacodynamics, School of Pharmacy and Pharmaceutical Sciences Buffalo and The New York State Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, NY 14260, USA 2Institute of Medical Microbiology, University of Münster, Münster, Germany 3Roswell Park Cancer Institute, Department of Medicine, Buffalo, NY 14263, USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号